SD
Sunil Dutt
About Sunil Dutt
Data last updated:
Sunil Dutt is a Director at Smithways Pharma Private Limited (since 2019) and Director at Smithways Health Care Private Limited (since 2016). The companies operate in Chemicals and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹4.98 Cr; the largest is Smithways Pharma Private Limited at ₹2.49 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Sep 2019 | 2019 | ₹2.49 Cr (FY 2025) | Active | |
| Director | 08 Jan 2016 | 2016 | ₹2.49 Cr (FY 2025) | Active |
Board colleagues of Sunil Dutt
| Name | DIN | Company | Designation |
|---|---|---|---|
| Navrati Rajpurohit | 08338755 | Smithways Pharma Private Limited , Smithways Health Care Private Limited | Additional Director |
| Sajjan Rajpurohit | 06913180 | Smithways Health Care Private Limited | Director |
| Sudarshan Pratap Singh Sajwan | 07906002 | Smithways Health Care Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunil Dutt
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunil Dutt
Sunil Dutt currently holds 2 directorships: Smithways Pharma Private Limited (Director, since 29 Sep 2019, revenue ₹2.49 Cr (FY 2025)); Smithways Health Care Private Limited (Director, since 08 Jan 2016, revenue ₹2.49 Cr (FY 2025)).
Sunil Dutt was first appointed on 08 Jan 2016 as Director at Smithways Health Care Private Limited. The most recent appointment on record is 29 Sep 2019 at Smithways Pharma Private Limited.
The 2 current companies of Sunil Dutt that report revenue have a combined latest revenue of ₹4.98 Cr: Smithways Pharma Private Limited ₹2.49 Cr (FY 2025); Smithways Health Care Private Limited ₹2.49 Cr (FY 2025).
The current boards of Sunil Dutt's companies include Navrati Rajpurohit (Smithways Pharma Private Limited), Sajjan Rajpurohit (Smithways Health Care Private Limited), Sudarshan Pratap Singh Sajwan (Smithways Health Care Private Limited).